BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 7884953)

  • 41. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.
    Craft S; Asthana S; Schellenberg G; Baker L; Cherrier M; Boyt AA; Martins RN; Raskind M; Peskind E; Plymate S
    Ann N Y Acad Sci; 2000 Apr; 903():222-8. PubMed ID: 10818510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.
    Seshadri S; Drachman DA; Lippa CF
    Arch Neurol; 1995 Nov; 52(11):1074-9. PubMed ID: 7487559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein E polymorphism in elderly east Africans.
    Sayi JG; Patel NB; Premkumar DR; Adem A; Winblad B; Matuja WB; Mtui EP; Gatere S; Friedland RP; Koss E; Kalaria RN
    East Afr Med J; 1997 Oct; 74(10):668-70. PubMed ID: 9529753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.
    Tanaka S; Kawamata J; Shimohama S; Akaki H; Akiguchi I; Kimura J; Ueda K
    Dement Geriatr Cogn Disord; 1998; 9(2):90-8. PubMed ID: 9524800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.
    Kosunen O; Talasniemi S; Lehtovirta M; Heinonen O; Helisalmi S; Mannermaa A; Paljärvi L; Ryynänen M; Riekkinen PJ; Soininen H
    Stroke; 1995 May; 26(5):743-8. PubMed ID: 7740560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
    Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
    Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.
    Growdon JH; Locascio JJ; Corkin S; Gomez-Isla T; Hyman BT
    Neurology; 1996 Aug; 47(2):444-8. PubMed ID: 8757018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
    Mielke R; Zerres K; Uhlhaas S; Kessler J; Heiss WD
    Neurosci Lett; 1998 Sep; 254(1):49-52. PubMed ID: 9780089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.
    Ossenkoppele R; van der Flier WM; Zwan MD; Adriaanse SF; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van Berckel BN
    Neurology; 2013 Jan; 80(4):359-65. PubMed ID: 23255822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.
    González C; Martín T; Cacho J; Breñas MT; Arroyo T; García-Berrocal B; Navajo JA; González-Buitrago JM
    Eur J Clin Invest; 1999 Jul; 29(7):637-42. PubMed ID: 10411671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ApoE polymorphism in Polish patients with Alzheimer's disease.
    Lalowski MM; Czyzewski K; Pfeffer A; Barcikowska M; Kwieciński H
    Acta Neurobiol Exp (Wars); 1998; 58(1):65-8. PubMed ID: 9583189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.